Parkworth Wealth Management, Inc. Corcept Therapeutics Inc Transaction History
Parkworth Wealth Management, Inc.
- $120 Billion
- Q4 2024
A detailed history of Parkworth Wealth Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 3 shares of CORT stock, worth $202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$202% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
364Shares Held
86.3MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$1.12 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$676 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$547 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$440 Million0.48% of portfolio
-
Parallel Advisors, LLC3.83MShares$259 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.23B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...